US2008206863A1PendingUtilityA1

Embryonic stem cells capable of differentiating into desired cells lines

Assignee: DIACRIN INCPriority: Nov 3, 1993Filed: Apr 16, 2008Published: Aug 28, 2008
Est. expiryNov 3, 2013(expired)· nominal 20-yr term from priority
C12N 2510/00C12N 2501/11C12N 2500/84C12N 2501/18C07K 14/715C12N 2501/39C12N 2501/36C12N 5/0619C12N 2500/25C12N 5/0068G01N 33/5005C12N 2501/395C07K 14/475C12N 2501/91C12N 2500/36C12N 2506/02
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An embryonic stem cell which may be induced to differentiate homogeneously into a desired primary cell line. The embryonic stem cell may be engineered with DNA, which encodes a protein or polypeptide which promotes differentiation of the stem cell into a specific cell line, such as, for example, a neuronal cell line, a muscle cell line, or a hematopoietic cell line. The DNA may encode a transcription factor found in the particular cell line. In another alternative, a desired cell line is produced from embryonic stem cells by culturing embryonic stem cells under conditions which provide for a three-dimensional network of embryonic stem cells, and then stimulating embryonic stem cells with an agent, such as retinoic acid, or dimethylsulfoxide, which promotes differentiation of the embryonic stem cells into the desired cell line, such as, for example, a neuronal cell line, or a muscle cell line.

Claims

exact text as granted — not AI-modified
1 - 29 . (canceled) 
     
     
         30 . An embryonic stem cell, said embryonic stem cell having been genetically engineered with DNA which encodes MyoD, which promotes differentiation of said embryonic stem cell into a muscle cell.

Join the waitlist — get patent alerts

Track US2008206863A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.